Last update Dec. 16, 2022
Compatible
We do not have alternatives for Bictegravir since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Bictegravir in other languages or writings:
Main tradenames from several countries containing Bictegravir in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Bictegravir is an integrase inhibitor used to treat HIV infection and AIDS. Oral administration once daily in fixed-dose combination with tenofovir alafenamide fumarate (TAF) and emtricitabine (FTC).
It is excreted in breast milk in clinically insignificant amounts. (Aebi 2022)
Plasma levels in an infant were 2% of maternal plasma levels. (Aebi 2022)
One of these antiretroviral treatment (ART) regimens is recommended for nursing mothers diagnosed with acute HIV infection (Panel USA 2022):
See below the information of this related product: